Steven P Dunn1, Robin L Gal, Craig Kollman, Dan Raghinaru, Mariya Dontchev, Christopher L Blanton, Edward J Holland, Jonathan H Lass, Kenneth R Kenyon, Mark J Mannis, Shahzad I Mian, Christopher J Rapuano, Walter J Stark, Roy W Beck. 1. *Michigan Cornea Consultants and Department of Ophthalmology, Oakland University/William Beaumont School of Medicine, Southfield-Rochester, MI; †Jaeb Center for Health Research, Tampa, FL; ‡Inland Eye Institute, Colton, CA; §Cincinnati Eye Institute and Department of Ophthalmology, University of Cincinnati, Cincinnati, OH; ¶Case Western Reserve University and University Hospitals Eye Institute, Cleveland, OH; ‖Eye Health Vision Center, Tufts University School of Medicine, Harvard Medical School, Boston, MA; **University of California Davis, Sacramento, CA; ††WK Kellogg Eye Center, the University of Michigan, Ann Arbor, MI; ‡‡Corneal Associates, PC, Wills Eye Hospital, Philadelphia, PA; and §§The Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
PURPOSE: The aim of this study was to assess the effect of donor and recipient factors on corneal allograft rejection and evaluate whether a rejection event was associated with graft failure. METHODS: One thousand ninety subjects undergoing penetrating keratoplasty for a moderate risk condition (principally Fuchs dystrophy or pseudophakic corneal edema) were followed for up to 12 years. Associations of baseline recipient and donor factors with the occurrence of a rejection event were assessed in univariate and multivariate proportional hazards models. RESULTS: Among 651 eyes with a surviving graft at 5 years, the 10-year graft failure (±99% confidence interval) rates were 12% ± 4% among eyes with no rejection events in the first 5 years, 17% ± 12% in eyes with at least 1 probable, but no definite rejection event, and 22% ± 20% in eyes with at least 1 definite rejection event. The only baseline factor significantly associated with a higher risk of definite graft rejection was a preoperative history of glaucoma, particularly when previous glaucoma surgery had been performed and glaucoma medications were being used at the time of transplant (10-year incidence 35% ± 23% compared with 14% ± 4% in eyes with no history of glaucoma/intraocular pressure treatment, P = 0.008). CONCLUSIONS: Patients who experienced a definite rejection event frequently developed graft failure raising important questions as to how we might change acute and long-term corneal graft management. Multivariate analysis indicated that previous use of glaucoma medications and glaucoma filtering surgery was a significant risk factor related to a definite rejection event.
PURPOSE: The aim of this study was to assess the effect of donor and recipient factors on corneal allograft rejection and evaluate whether a rejection event was associated with graft failure. METHODS: One thousand ninety subjects undergoing penetrating keratoplasty for a moderate risk condition (principally Fuchs dystrophy or pseudophakic corneal edema) were followed for up to 12 years. Associations of baseline recipient and donor factors with the occurrence of a rejection event were assessed in univariate and multivariate proportional hazards models. RESULTS: Among 651 eyes with a surviving graft at 5 years, the 10-year graft failure (±99% confidence interval) rates were 12% ± 4% among eyes with no rejection events in the first 5 years, 17% ± 12% in eyes with at least 1 probable, but no definite rejection event, and 22% ± 20% in eyes with at least 1 definite rejection event. The only baseline factor significantly associated with a higher risk of definite graft rejection was a preoperative history of glaucoma, particularly when previous glaucoma surgery had been performed and glaucoma medications were being used at the time of transplant (10-year incidence 35% ± 23% compared with 14% ± 4% in eyes with no history of glaucoma/intraocular pressure treatment, P = 0.008). CONCLUSIONS:Patients who experienced a definite rejection event frequently developed graft failure raising important questions as to how we might change acute and long-term corneal graft management. Multivariate analysis indicated that previous use of glaucoma medications and glaucoma filtering surgery was a significant risk factor related to a definite rejection event.
Authors: L Malvitte; T Montange; A Vejux; C Baudouin; A M Bron; C Creuzot-Garcher; G Lizard Journal: Br J Ophthalmol Date: 2006-08-30 Impact factor: 4.638
Authors: Steven P Dunn; Walter J Stark; R Doyle Stulting; Jonathan H Lass; Alan Sugar; Mark A Pavilack; Patricia W Smith; Jean Paul Tanner; Mariya Dontchev; Robin L Gal; Roy W Beck; Craig Kollman; Mark J Mannis; Edward J Holland Journal: Am J Ophthalmol Date: 2008-12-04 Impact factor: 5.258
Authors: Keryn A Williams; Adrian J Esterman; Christine Bartlett; Helene Holland; Ngaere B Hornsby; Douglas J Coster Journal: Transplantation Date: 2006-03-27 Impact factor: 4.939
Authors: Rosalind M K Stewart; Mark N A Jones; Mark Batterbury; Derek Tole; Daniel F P Larkin; Stephen B Kaye Journal: Am J Ophthalmol Date: 2010-12-18 Impact factor: 5.258
Authors: Alan Sugar; Robin L Gal; roy W Beck; Katrina J Ruedy; Christopher L Blanton; Robert S Feder; David R Hardten; Edward J Holland; Jonathan H Lass; Mark J Mannis; Michael B O'Keefe Journal: Cornea Date: 2005-05 Impact factor: 2.651
Authors: Beth Ann Benetz; Robin L Gal; Katrina J Ruedy; Carmella Rice; Roy W Beck; Andrea D Kalajian; Jonathan H Lass Journal: Curr Eye Res Date: 2006-04 Impact factor: 2.424
Authors: Alan Sugar; Jean Paul Tanner; Mariya Dontchev; Brad Tennant; Robert L Schultze; Steven P Dunn; Thomas D Lindquist; Robin L Gal; Roy W Beck; Craig Kollman; Mark J Mannis; Edward J Holland Journal: Ophthalmology Date: 2009-04-23 Impact factor: 12.079
Authors: Yuan Tian; Mark Draelos; Ryan P McNabb; Kris Hauser; Anthony N Kuo; Joseph A Izatt Journal: Biomed Opt Express Date: 2022-08-31 Impact factor: 3.562
Authors: Brenton Keller; Mark Draelos; Kevin Zhou; Ruobing Qian; Anthony Kuo; George Konidaris; Kris Hauser; Joseph Izatt Journal: IEEE Trans Robot Date: 2020-04-16 Impact factor: 6.835
Authors: Katie X Li; Asad F Durrani; Yunshu Zhou; Peter Y Zhao; Bradford L Tannen; Shahzad I Mian; David C Musch; David N Zacks Journal: Cornea Date: 2021-11-10 Impact factor: 3.152
Authors: Mark Draelos; Gao Tang; Brenton Keller; Anthony Kuo; Kris Hauser; Joseph A Izatt Journal: IEEE Trans Biomed Eng Date: 2019-11-20 Impact factor: 4.538
Authors: R Doyle Stulting; Jonathan H Lass; Mark A Terry; Beth Ann Benetz; Nathan J Cohen; Allison R Ayala; Maureen G Maguire; Christopher Croasdale; Yassine J Daoud; Steven P Dunn; Kenneth M Goins; Pankaj C Gupta; Marian S Macsai; Shahzad I Mian; Sudeep Pramanik; Jennifer Rose-Nussbaumer; Jonathan C Song; Walter J Stark; Alan Sugar; David D Verdier; Loretta B Szczotka-Flynn Journal: Am J Ophthalmol Date: 2018-10-09 Impact factor: 5.258